Life ScienceCompany
Where is Idorsia Pharmaceuticals headquartered?
Idorsia Pharmaceuticals is headquartered in Allschwil, Switzerland.
What sector is Idorsia Pharmaceuticals in?
Idorsia Pharmaceuticals is a life science company.
Idorsia Pharmaceuticals is headquartered in Allschwil, Switzerland.
Idorsia Pharmaceuticals is a life science company.
Hegenheimermattweg 91,
Allschwil,
4123
Switzerland,
+41 58 844 00 00
www.idorsia.com
Idorsia Pharmaceuticals Ltd. is a developer of selatogrel, a potent, fast-acting, reversible, and highly-selective P2Y12 receptor antagonist, for single subcutaneous self-administration for the treatment of a suspected AMI in patients with a history of AMI. Idorsia has previously announced that two Phase 2 studies in patients with stable coronary artery disease and acute myocardial infarction, respectively, have met their pharmacodynamic objectives of significantly inhibiting platelet aggregation. Idorsia Pharmaceuticals is based in Allschwil, Switzerland.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
